Gates-backed study of faster tu­ber­cu­lo­sis drug treat­ments kicks off in South Africa

An im­por­tant test of new drugs that aim to treat tu­ber­cu­lo­sis in­fec­tions more ef­fi­cient­ly has be­gun in South Africa.
The Phase II clin­i­cal tri­al, spon­sored …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER